Advancements and Future Directions of Dual-Target Chimeric Antigen Receptor T-Cell Therapy in Preclinical and Clinical Studies
In recent years, chimeric antigen receptor T-cell (CAR-T) therapy has made groundbreaking progress in the treatment of various cancer types, particularly hematological malignancies. In the meantime, various preclinical and clinical studies have extensively explored dual-target CAR-T therapies which...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/jimr/5845167 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832591086987509760 |
|---|---|
| author | Chenyun Zhang Haizhou Liu |
| author_facet | Chenyun Zhang Haizhou Liu |
| author_sort | Chenyun Zhang |
| collection | DOAJ |
| description | In recent years, chimeric antigen receptor T-cell (CAR-T) therapy has made groundbreaking progress in the treatment of various cancer types, particularly hematological malignancies. In the meantime, various preclinical and clinical studies have extensively explored dual-target CAR-T therapies which can be designed to recognize two antigens simultaneously based on the immunophenotype of tumor cells. Compared with single-target CAR-T approach, dual-target CAR-T therapies demonstrate varying degrees of superior antitumor CAR effects, prevent antigen escape and relapse, reduce on-target off-tumor effects, and ensure durable responses in different types of cancer. These advantages highlight the potential future prospects in this field, showing varying degrees of advancement in preclinical and clinical studies. Herein, we aimed to review different dual-target CAR-T studies conducted on a wide range of tumor models, summarizing the selection of target combinations, the efficacy and safety demonstrated in preclinical and clinical settings, the existing limitations, and the potential future directions of this promising therapeutic strategy. |
| format | Article |
| id | doaj-art-350e7e9cf8ad49ee9e5f33312c3e3c2e |
| institution | Kabale University |
| issn | 2314-7156 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-350e7e9cf8ad49ee9e5f33312c3e3c2e2025-01-23T05:00:02ZengWileyJournal of Immunology Research2314-71562025-01-01202510.1155/jimr/5845167Advancements and Future Directions of Dual-Target Chimeric Antigen Receptor T-Cell Therapy in Preclinical and Clinical StudiesChenyun Zhang0Haizhou Liu1School of MedicineDivision of Hematology-OncologyIn recent years, chimeric antigen receptor T-cell (CAR-T) therapy has made groundbreaking progress in the treatment of various cancer types, particularly hematological malignancies. In the meantime, various preclinical and clinical studies have extensively explored dual-target CAR-T therapies which can be designed to recognize two antigens simultaneously based on the immunophenotype of tumor cells. Compared with single-target CAR-T approach, dual-target CAR-T therapies demonstrate varying degrees of superior antitumor CAR effects, prevent antigen escape and relapse, reduce on-target off-tumor effects, and ensure durable responses in different types of cancer. These advantages highlight the potential future prospects in this field, showing varying degrees of advancement in preclinical and clinical studies. Herein, we aimed to review different dual-target CAR-T studies conducted on a wide range of tumor models, summarizing the selection of target combinations, the efficacy and safety demonstrated in preclinical and clinical settings, the existing limitations, and the potential future directions of this promising therapeutic strategy.http://dx.doi.org/10.1155/jimr/5845167 |
| spellingShingle | Chenyun Zhang Haizhou Liu Advancements and Future Directions of Dual-Target Chimeric Antigen Receptor T-Cell Therapy in Preclinical and Clinical Studies Journal of Immunology Research |
| title | Advancements and Future Directions of Dual-Target Chimeric Antigen Receptor T-Cell Therapy in Preclinical and Clinical Studies |
| title_full | Advancements and Future Directions of Dual-Target Chimeric Antigen Receptor T-Cell Therapy in Preclinical and Clinical Studies |
| title_fullStr | Advancements and Future Directions of Dual-Target Chimeric Antigen Receptor T-Cell Therapy in Preclinical and Clinical Studies |
| title_full_unstemmed | Advancements and Future Directions of Dual-Target Chimeric Antigen Receptor T-Cell Therapy in Preclinical and Clinical Studies |
| title_short | Advancements and Future Directions of Dual-Target Chimeric Antigen Receptor T-Cell Therapy in Preclinical and Clinical Studies |
| title_sort | advancements and future directions of dual target chimeric antigen receptor t cell therapy in preclinical and clinical studies |
| url | http://dx.doi.org/10.1155/jimr/5845167 |
| work_keys_str_mv | AT chenyunzhang advancementsandfuturedirectionsofdualtargetchimericantigenreceptortcelltherapyinpreclinicalandclinicalstudies AT haizhouliu advancementsandfuturedirectionsofdualtargetchimericantigenreceptortcelltherapyinpreclinicalandclinicalstudies |